Tag: Pharma
MEI Pharma Announces Results of Special Meeting of Stockholders – MEI...
MEI Pharma, Inc. MEIP (the "Company") today announced that, based on a count of the votes cast at the Company's Special Meeting of...
Small Pharma Announces Management Team Change – Small Pharma (OTC:DMTTF) –...
LONDON, July 05, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. DMT DMTTF (the "Company" or "Small Pharma"), a biotechnology company focused...
Small Pharma Reports Financial Results for the Fiscal Year Ended February...
• Multiple clinical milestones achieved including the first proof-of-concept for DMT-based therapies from a blinded placebo-controlled study• Preliminary findings from SPL028 Phase I...
Innate Pharma Highlights Proprietary Tetra-specific ANKET® NK Cell Engager IPH65… –...
IPH6501 is a first-in-class tetra-specific antibody-based natural killer cell engager therapeutic, based on ANKET® platform, targeting CD20 developed for the treatment of B-cell...
NewAmsterdam Pharma Announces Pricing of Upsized Secondary Offering of Ordinary …...
NAARDEN, The Netherlands and MIAMI, June 06, 2023 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. NAMS "NewAmsterdam" or the "Company"))), a...
Live from ASCO 2023 | Ascentage Pharma Releases Updated Data Showing...
SUZHOU, China and ROCKVILLE, Md., June 6, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer,...
HOOKIPA Pharma Announces Positive Preliminary Phase 2 Data on HB-200 in...
HB-200 in combination with pembrolizumab doubled the objective response rate of 1st-line pembrolizumab for patients with recurrent/metastatic head and neck cancerHOOKIPA is preparing...
MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal – MEI Pharma...
MEI Pharma, Inc. MEIP (the "Company") today confirmed receipt of an unsolicited and non-binding proposal on May 23, 2023 from a group represented...
Ascendis Pharma Showcases Commitment to Rare Endocrine Diseases at the 25th...
COPENHAGEN, Denmark, May 13, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S ASND today announced the company will present clinical and research...
Global Pharma, Biotech and Diagnostics Option and Evaluation Partnership Analysi… –...
DUBLIN, May 8, 2023 /PRNewswire/ -- The "Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023" report has been...